Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1

Cited by (660)

Items 101–200 of 660

1. MAX Inactivation in Small Cell Lung Cancer Disrupts MYC–SWI/SNF Programs and Is Synthetic Lethal with BRG1
   Octavio A. Romero, Manuel Torres-Diz, Eva Pros, Suvi P. Savola, Antonio Gómez, Sebastián Morán, Carmen Sáez, Reika Iwakawa, Alberto Villanueva, Luis M. Montuenga et al. · 2013 · Cancer Discovery
2. Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion
   Peter A. Kreuzaler, Yulia Panina, Joanna Segal, M. Yuneva · 2019 · Molecular Metabolism
3. Targeting cancer metabolism – aiming at a tumour's sweet-spot
   Neil P. Jones, Almut Schulze · 2011 · Drug Discovery Today
4. HIF-1 reduces ischaemia–reperfusion injury in the heart by targeting the mitochondrial permeability transition pore
   Sang‐Ging Ong, Won Hee Lee, Louise Theodorou, Kazuki Kodo, Shiang Yong Lim, Deepa Shukla, Thomas Briston, Serafim Kiriakidis, Margaret A. Ashcroft, Sean M. Davidson et al. · 2014 · Cardiovascular Research
5. Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells
   Lakshmipathi Vadlakonda, Mukesh Pasupuleti, Pallu Reddanna · 2013 · Frontiers in Oncology
6. Metabolic consequences of oncogenic IDH mutations
   Seth J. Parker, Christian M. Metallo · 2015 · Pharmacology & Therapeutics
7. Mitochondrial Sirtuins and Their Relationships with Metabolic Disease and Cancer
   Surinder Kumar, David B. Lombard · 2014 · Antioxidants and Redox Signaling
8. Combinatorial regulation of neuroblastoma tumor progression by N-Myc and hypoxia inducible factor HIF-1α
   Qing, Guoliang, Skuli, Nicolas, Mayes, Patrick A., Pawel, Bruce, Martinez, Daniel, Maris, John M., Simon, M. Celeste · 2010 · Cancer Research
9. Regulation of gene transcription by the oncoprotein MYC
   Bernhard Lüscher, Jörg Vervoorts · 2011 · Gene
10. Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
    Runze Shang, Shibin Qu, Desheng Wang · 2016 · World Journal of Gastroenterology
11. The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation
    Xuemei Tong, Fangping Zhao, Anthony Mancuso, Joshua James Gruber, Craig B. Thompson · 2009 · Proceedings of the National Academy of Sciences
12. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC
    Luke H. Stockwin, Sherry X. Yu, Suzanne D. Borgel, Chad N. Hancock, Tracy L. Wolfe, Lawrence R. Phillips, Melinda G. Hollingshead, Dianne L. Newton · 2010 · International Journal of Cancer
13. Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?
    Wen Zhang, Shaolin Zhang, Xiaohui Hu, Kin Yip Tam · 2015 · International Journal of Biological Sciences
14. Small-molecule inhibitors of the Myc oncoprotein
    Steven Fletcher, Edward V. Prochownik · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
15. p53 and metabolism: from mechanism to therapeutics
    Fernando Moreira Simabuco, Mirian Galliote Morale, Isadora Carolina Betim Pavan, Ana Paula Morelli, Fernando Riback Silva, Rodrigo Esaki Tamura · 2018 · Oncotarget
16. Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells
    Petra Jagušt, Beatriz de Luxán‐Delgado, Beatriz Parejo-Alonso, Patricia Sancho · 2019 · Frontiers in Pharmacology
17. Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis
    Ke Jin, Shufei Wang, Yazhuo Zhang, Mengfang Xia, Yongzhen Mo, Xiaoling Li, Guiyuan Li, Zhaoyang Zeng, Wei Xiong, Yi He · 2019 · Cellular and Molecular Life Sciences
18. The Metabolic Fates of Pyruvate in Normal and Neoplastic Cells
    Edward V. Prochownik, Huabo Wang · 2021 · Cells
19. Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications
    Xiuxiu Wang, Xiaoyue Shen, Yuting Yan, Hongmin Li · 2021 · Bioscience Reports
20. Myc Posttranscriptionally Induces HIF1 Protein and Target Gene Expression in Normal and Cancer Cells
    Megan R. Doe, Janice M. Ascano, Mandeep Kaur, Michael D. Cole · 2011 · Cancer Research
21. Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy
    Varda Shoshan‐Barmatz, Maya Golan · 2012 · Current Medicinal Chemistry
22. Metabolic flux rewiring in mammalian cell cultures
    Jamey D. Young · 2013 · Current Opinion in Biotechnology
23. Voltage‐dependent anion channel 1 is involved in endostatin‐induced endothelial cell apoptosis
    Shaopeng Yuan, Yan Fu, Xiaofeng Wang, Hubing Shi, Yujie Huang, Xiaomin Song, Ling Li, Nan Song, Yongzhang Luo · 2008 · The FASEB Journal
24. STAT3-Mediated Metabolic Reprograming in Cellular Transformation and Implications for Drug Resistance
    Valeria Poli, Annalisa Camporeale · 2015 · Frontiers in Oncology
25. Metabolic alterations in cancer cells and therapeutic implications
    Naima Hammoudi, Kausar Begam Riaz Ahmed, Celia Garcı́a-Prieto, Peng Huang · 2011 · 癌症：英文版
26. Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas
    Alexandre Vallée, Rémy Guillevin, Jean-Noël Vallée · 2017 · Reviews in the Neurosciences
27. The Interplay Between MYC and HIF in the Warburg Effect
    Chi Van Dang · 2008 · Ernst Schering Research Foundation workshop/Ernst Schering Foundation Symposium proceedings
28. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells
    Sai-Wen Tang, Wen-Hsin Chang, Yih-Ching Su, Yu‐Chi Chen, Yen-Han Lai, Pei-Tzu Wu, Chyong‐Ing Hsu, Wei‐Chou Lin, Ming‐Kuen Lai, Jung‐Yaw Lin · 2008 · Cancer Letters
29. The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry
    Fionnuala M. Morrish, Nicola Neretti, John M. Sedivy, David M. Hockenbery · 2008 · Cell Cycle
30. Carrot and stick: HIF-α engages c-Myc in hypoxic adaptation
    Eric L. Huang · 2008 · Cell Death and Differentiation
31. LncRNA IDH1-AS1 links the functions of c-Myc and HIF1α via IDH1 to regulate the Warburg effect
    Xiang, Shaoxun, Gu, Hao, Jin, Lei, Thorne, Rick F., Zhang, Xu Dong, Wu, Mian · 2018 · Proceedings of the National Academy of Sciences
32. Myc Is a Metastasis Gene for Non-Small-Cell Lung Cancer
    Ulf Rüdiger Rapp, Christian B. Korn, Fatih Ceteci, Christiaan Karreman, Katharina Luetkenhaus, Valentina Serafin, Emanuele Zanucco, Inês C. Castro, Tamara Potapenko · 2009 · PLoS ONE
33. Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
    Faiqa Mudassar, Han M. Shen, Geraldine Margaret O’Neill, Eric K.C. Hau · 2020 · Journal of Experimental & Clinical Cancer Research
34. The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells?
    Rafael Moreno‐Sánchez, Sara Rodríguez‐Enríquez, Emma Saavedra, Álvaro Marín‐Hernández, Juan Carlos Gallardo‐Pérez · 2009 · BioFactors
35. Glucose Metabolic Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming
    Han, Rongrong, Liang, Jing, Zhou, Bing · 2021 · International Journal of Molecular Sciences
36. Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect
    Xisha Chen, Lan-ya Li, Yi-di Guan, Jinming Yang, Yan Cheng · 2016 · Acta Pharmacologica Sinica
37. Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia
    Ralph V. Shohet, Joseph A. Garcia · 2007 · Journal of Molecular Medicine
38. Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53
    Joanna Zawacka‐Pankau, Vera V. Grinkevich, Sabine Hünten, Fedor Nikulenkov, Angela Gluch, Hai Li, Martin Enge, Alexander E Kel, Galina Selivanova · 2011 · Journal of Biological Chemistry
39. Metabolic reprogramming of the tumor
    Leonardo M. R. Ferreira, Aline Hébrant, J.E. Dumont · 2012 · Oncogene
40. Myc and its interactors take shape
    William B. Tu, Sara Helander, Robert Pilstål, K. Ashley Hickman, Corey Lourenco, Igor Jurišica, Brian Raught, Björn Wallner, Maria Sunnerhagen, Linda Z. Penn · 2014 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
41. Tumor mechanics and metabolic dysfunction
    Jason C. Tung, James Matthew Barnes, Shraddha R. Desai, Christopher Sistrunk, Matthew W. Conklin, Pepper S. Schedin, Kevin W. Eliceiri, Patricia J. Keely, Victoria L. Seewaldt, Valerie Marie Weaver · 2014 · Free Radical Biology and Medicine
42. TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells
    Daniel S. Straus · 2013 · Molecular Cancer
43. Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model
    Véronique Mathieu, Nancy De Nève, Marie Le Mercier, Janique Dewelle, Jean‐François Gaussin, Mischaël Dehoux, Robert Kiss A, Florence Lefranc · 2008 · Neoplasia
44. Tumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor Immunity
    Nicole E. Scharping, Greg M. Delgoffe · 2016 · Vaccines
45. Cancer metabolism: New insights into classic characteristics
    Yukio Kato, T Maeda, Atsuko Suzuki, Yuh Baba · 2017 · Japanese Dental Science Review
46. Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers
    John C. Chappell, Laura Beth Payne, W. Kimryn Rathmell · 2019 · Journal of Clinical Investigation
47. Micromanaging aerobic respiration and glycolysis in cancer cells
    Ayla Orang, Janni Petersen, Ross Allan McKinnon, Michael Michael · 2019 · Molecular Metabolism
48. Regulation of Glycolysis by Non-coding RNAs in Cancer: Switching on the Warburg Effect
    Hamed Mirzaei, Michael Richard Hamblin · 2020 · Molecular Therapy — Oncolytics
49. Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction
    Pötgens, Sarah A., Brossel, Hélène, Sboarina, Martina, Catry, Emilie, Cani, Patrice D., Neyrinck, Audrey M., Delzenne, Nathalie M., Bindels, Laure B. · 2018 · Scientific Reports
50. Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma
    Peter Hersey, Xu Dong Zhang · 2008 · Pigment Cell & Melanoma Research
51. Molecular mechanisms of carbonic anhydrase IX‐mediated pH regulation under hypoxia
    Silvia Pastoreková, Peter John Ratcliffe, Jaromı́r Pastorek · 2008 · British Journal of Urology
52. Targeting Cancer Metabolism - Revisiting the Warburg Effects
    Quangdon Tran, Hyunji Lee, Jisoo Park, Seon‐Hwan Kim, Jongsun Park · 2016 · Toxicological Research
53. The tumor suppressor function of mitochondria: Translation into the clinics
    Jose Manuel Cuezva, Alvaro Darío Ortega, Imke M. Willers, Laura Sánchez-Cenizo, Marcos Aldea, María Sánchez‐Aragó · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
54. Metabolomics and Metabolic Reprogramming in Kidney Cancer
    Robert H. Weiss · 2018 · Seminars in Nephrology
55. EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect
    Qilin Xu, Qunzhou Zhang, Yasutaka Ishida, Souren Hajjar, Xudong Tang, Haoran Shi, Chi Van Dang, Anh D. Le · 2016 · Oncotarget
56. Regulation of Cancer Metabolism by Oncogenes and Tumor Suppressors
    Raffaella Iurlaro, Clara Lucía León‐Annicchiarico, Cristina Muñoz‐Pinedo · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
57. Molecular Pathways: Targeting MYC-induced Metabolic Reprogramming and Oncogenic Stress in Cancer
    Bo Li, Marie Celeste Simon · 2013 · Clinical Cancer Research
58. The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells
    Daniele Cretella, Andrea Ravelli, Claudia Fumarola, Silvia La Monica, Graziana Digiacomo, Andrea Cavazzoni, Roberta R Alfieri, Alessandra Biondi, Daniele Generali, Mara A. Bonelli et al. · 2018 · Journal of Experimental & Clinical Cancer Research
59. Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer
    Aparna B. Shinde, Tomasz Maciej Wilmanski, Hao Chen, Dorothy Teegarden, Michael K. Wendt · 2018 · Breast Cancer Research
60. Clotrimazole Preferentially Inhibits Human Breast Cancer Cell Proliferation, Viability and Glycolysis
    Cristiane M. Furtado, Mariah Celestino Marcondes, Mauro Sola‐Penna, Maisa L. S. de Souza, Patrícia Zancan · 2012 · PLoS ONE
61. tRNA synthetase counteracts c-Myc to develop functional vasculature
    Yi Shi, Xiaoling Xu, Qian Zhang, Guangsen Fu, Zhongying Mo, George S Wang, Shuji Kishi, Xiang‐Lei Yang · 2014 · eLife
62. Therapeutic Targeting of Myc-Reprogrammed Cancer Cell Metabolism
    Chi Van Dang · 2011 · Cold Spring Harbor Symposia on Quantitative Biology
63. Pyruvate Carboxylase Is Up-Regulated in Breast Cancer and Essential to Support Growth and Invasion of MDA-MB-231 Cells
    Phatchariya Phannasil, Chanitra Thuwajit, Malee Warnnissorn, John C. Wallace, Michael J. MacDonald, Sarawut Jitrapakdee · 2015 · PLoS ONE
64. Lactate and lactylation: Behind the development of tumors
    Enci Dai, Wei Wang, Yingying Li, Defeng Ye, Yanli Li · 2024 · Cancer Letters
65. Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis
    Xue Han, Chune Ren, Chao Lü, Pengyun Qiao, Tingting Yang, Zhenhai Yu · 2022 · Cell Death and Differentiation
66. A tumor suppressor role for C/EBPα in solid tumors: more than fat and blood
    Ana Rita Lourenço, Paul James Coffer · 2017 · Oncogene
67. Interactions between PPAR Gamma and the Canonical Wnt/Beta-Catenin Pathway in Type 2 Diabetes and Colon Cancer
    Yves Lecarpentier, VICTOR A. CLAES, Alexandre Vallée, Jean‐Louis Hébert · 2017 · PPAR Research
68. The Key Role of the WNT/β-Catenin Pathway in Metabolic Reprogramming in Cancers under Normoxic Conditions
    Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée · 2021 · Cancers
69. Silencing of Elongation Factor-2 Kinase Potentiates the Effect of 2-Deoxy- d -Glucose against Human Glioma Cells through Blunting of Autophagy
    Hao Wu, Hua Zhu C, David X. Liu, Ting-Kuang Niu, Xingcong Ren, Rajesh Patel, William N. Hait, Jinming Yang · 2009 · Cancer Research
70. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression
    Xinyuan Xu, Jianying Li, Xiang Yu Sun, Yan Hua Guo, Dake Chu, Li Wei, Xia Li, Guodong Yang, Xinping Liu, Libo Yao et al. · 2015 · Oncotarget
71. Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520
    Yun‐Yong Park, Sang-Bae Kim, Hee Dong Han, Bo Hwa Sohn, Ji Hoon Kim, Jiyong Liang, Yiling Lu, Cristian Rodriguez‐Aguayo, Gabriel Lopez‐Berestein, Gordon Brent Mills et al. · 2013 · Hepatology
72. CDK8 Kinase Activity Promotes Glycolysis
    Matthew D. Galbraith, Zdeněk Andrysík, Ahwan Pandey, Maria Hoh, Elizabeth A. Bonner, Amanda A. Hill, Kelly D. Sullivan, Joaquin Maximiliano Espinosa · 2017 · Cell Reports
73. TIGAR, TIGAR, burning bright
    Pearl Lee, Karen H. Vousden, Eric C. Cheung · 2014 · Cancer & Metabolism
74. KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis
    Ling‐Yu Wang, Chiu-Lien Hung, Yun-Ru Chen, Joy C. Yang, Junjian Wang, Mel Campbell, Yoshihiro Izumiya, Hong-Wu Chen, Wen‐Ching Wang, David Kong Ann et al. · 2016 · Cell Reports
75. Is Lactate an Oncometabolite? Evidence Supporting a Role for Lactate in the Regulation of Transcriptional Activity of Cancer-Related Genes in MCF7 Breast Cancer Cells
    Iñigo San-Millán, Colleen Glyde Julian, Christopher J. Matarazzo, Janel L. Martinez, George A. Brooks · 2020 · Frontiers in Oncology
76. Regulators of glucose uptake in thyroid cancer cell lines
    Shabnam Heydarzadeh, Ali Asghar Moshtaghie, Maryam Sadat Daneshpoor, Mehdi Hedayati · 2020 · Cell Communication and Signaling
77. Restoration of mitochondria function as a target for cancer therapy
    Tariq A. Bhat, Sandeep Kumar, Ajay Kumar Chaudhary, Neelu Yadav, Dhyan Chandra · 2015 · Drug Discovery Today
78. NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma
    Robin Kit‐Ho Lai, Mingjing Xu, David Kung‐Chun Chiu, Aki Pui‐Wah Tse, Larry Lai Wei, Cheuk‐Ting Law, Derek Pok Him Lee, Chun‐Ming Wong, Maria Pik Wong, Irene Oi‐Lin Ng et al. · 2016 · Clinical Cancer Research
79. Insidious role of nitric oxide in migration/invasion of colon cancer cells by upregulating MMP-2/9 via activation of cGMP-PKG-ERK signaling pathways
    Suboj Babykutty, Priya Suboj, Priya Srinivas, S. Asha Nair, Krishnan N Chandramohan, Srinivas Gopala · 2012 · Clinical & Experimental Metastasis
80. HIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanism
    Caroline M. Lambert, Mélanie Roy, Geneviève Robitaille, Darren E. Richard, Sébastien Bonnet · 2010 · Cardiovascular Research
81. Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development
    Petr Ježek, Lydie Plecitá‐Hlavatá, Katarína Smolková, Rodrigue Rossignol · 2009 · The International Journal of Biochemistry & Cell Biology
82. Molecular Biomarkers of Vascular Dysfunction in Obstructive Sleep Apnea
    Elżbieta Kaczmarek, Jessie P. Bakker, Douglas N. Clarke, Eva Csizmadia, Olivier N. Kocher, Aristidis Veves, Francesco Tecilazich, Christopher Paul O'Donnell, Christiane J. Ferran, Atul Malhotra · 2013 · PLoS ONE
83. Warburg effect hypothesis in autism Spectrum disorders
    Alexandre Vallée, Jean-Noël Vallée · 2018 · Molecular Brain
84. LAST, a c-Myc-inducible long noncoding RNA, cooperates with CNBP to promote CCND1 mRNA stability in human cells
    Limian Cao, Pengfei Zhang, Jinming Li, Mian Wu · 2017 · eLife
85. The role of hypoxia-inducible factors in neovascular age-related macular degeneration: a gene therapy perspective
    Parviz Mammadzada, Pablo Manuel Fernández Corredoira, Helder André · 2019 · Cellular and Molecular Life Sciences
86. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy
    Chunmei Fan, Shanshan Zhang, Zhaojian Gong, Xiayu Li, Bo Xiang, Hao Deng, Ming Zhou, Yong Li, Yong Li, Wei Xiong et al. · 2020 · Science China Life Sciences
87. Molecular Crosstalk Between MYC and HIF in Cancer
    Yanping Li, Xiao‐Xin Sun, David Z. Qian, Mu‐Shui Dai · 2020 · Frontiers in Cell and Developmental Biology
88. Extracellular Lumican Inhibits Pancreatic Cancer Cell Growth and Is Associated with Prolonged Survival after Surgery
    Xinqun Li, Mark A. Truty, Ya’an Kang, Xavier Chopin‐Laly, Ran Zhang, David Roife, Deyali Chatterjee, E. H. Lin, Ryan Michael Thomas, Huamin Wang et al. · 2014 · Clinical Cancer Research
89. A PKM2 signature in the failing heart
    Meredith L. Rees, Janani Subramaniam, Yuanteng Li, Dale J. Hamilton, Oscar Howard Frazier, Heinrich Taegtmeyer · 2015 · Biochemical and Biophysical Research Communications
90. MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities
    Abraham Pedroza‐Torres, Sandra Lorena Romero-Cordoba, Montserrat Justo-Garrido, Iván Salido-Guadarrama, Rubén Rodríguez‐Bautista, Sarita Montaño, Rodolfo Muñiz-Mendoza, Cristian Arriaga-Canon, Verónica Fragoso‐Ontiveros, Rosa María Álvarez-Gómez et al. · 2019 · Frontiers in Oncology
91. CDK7 inhibitor THZ1 enhances antiPD-1 therapy efficacy via the p38α/MYC/PD-L1 signaling in non-small cell lung cancer
    Jian Wang, Ruiguang Zhang, Zhenyu Lin, Sheng Zhang, Yaobing Chen, Jing Ping Tang, Jiaxin Hong, Xiaoshu Zhou, Yan Zong, Yingzhuo Xu et al. · 2020 · Journal of Hematology & Oncology
92. Delineation of the Key Aspects in the Regulation of Epithelial Monolayer Formation
    Lydia Aschauer, Leonhard N. Gruber, Walter Pfaller, Alice Limonciel, Toby James Athersuch, Rachel Cavill, Abdulhameed Khan, Gerhard J.A. Gstraunthaler, Johannes Grillari, Regina Grillari‐Voglauer et al. · 2013 · Molecular and Cellular Biology
93. Isotopically nonstationary 13C flux analysis of Myc-induced metabolic reprogramming in B-cells
    Taylor A. Murphy, Chi Van Dang, Jamey D. Young · 2012 · Metabolic Engineering
94. The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment
    Shuixian Li, Wen Meng, Ziwei Guan, Yuanling Guo, Xiuzhen Han · 2016 · Biomedicine & Pharmacotherapy
95. Transcriptional Regulation of Energy Metabolism in Cancer Cells
    Sara Rodríguez‐Enríquez, Álvaro Marín‐Hernández, Juan Carlos Gallardo‐Pérez, Silvia Cecilia Pacheco-Velázquez, Javier Belmont-Díaz, Diana Xochiquetzal Robledo‐Cadena, Jorge Luis Vargas-Navarro, Norma Angélica Corona de la Peña, Emma Saavedra, Rafael Moreno‐Sánchez · 2019 · Cells
96. JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification
    Wenyi Sun, Zuoquan Xie, Yifu Liu, Dan Zhao, Zhixiang Wu, Dadong Zhang, Hao Lv, Shuai Tang, Nan Jin, Hualiang Jiang et al. · 2015 · Cancer Research
97. Pre-treatment with the CDK4/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells
    Daniele Cretella, Claudia Fumarola, Mara A. Bonelli, Roberta R Alfieri, Silvia La Monica, Graziana Digiacomo, Andrea Cavazzoni, Maricla Galetti, Daniele Generali, Pier Giorgio Petronini · 2019 · Scientific Reports
98. Correction to: Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ
    Jing Cai, Mei Yi, Yixin Tan, Xiaoling Li, Guiyuan Li, Zhaoyang Zeng, Wei Xiong, Bo Xiang · 2021 · Journal of Experimental & Clinical Cancer Research
99. Chicken or the egg: Warburg effect and mitochondrial dysfunction
    Deniz Senyilmaz, Aurelio A. Teleman · 2015 · F1000Prime Reports
100. Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells
     Wenjia Zhang, Jing Su, Huadan Xu, Shanshan Yu, Yanan Liu, Yong Zhang, Liankun Sun, Ying Yue, Xiaoli Zhou · 2017 · PLoS ONE